Griffith DE, Aksamit T, Brown-Elliott BA , et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med, 2007,175(4):367-416.
[3]
O’Connell ML, Birkenkamp KE, Kleiner DE , et al. Lung manifestations in an autopsy-based series of pulmonary or disseminated nontuberculous mycobacterial disease. Chest, 2012,141(5):1203-1209.
[4]
Kim C, Park SH, Oh SY , et al. Comparison of chest CT findings in nontuberculous mycobacterial diseases vs. Mycobacterium tuberculosis lung disease in HIV-negative patients with cavities. PLoS One, 2017,12(3):e0174240.
[5]
Rokadiya S, Millar FR, Tiberi S . Non-tuberculous mycobacterial pulmonary disease: a clinical update. Br J Hosp Med (Lond), 2018,79(8):C118-122.
Furuuchi K, Ito A, Hashimoto T , et al. Clinical significance of the radiological severity score in Mycobacterium avium complex lung disease patients. Int J Tuberc Lung Dis, 2017,21(4):452-457.
Kim TS, Koh WJ, Han J , et al. Hypothesis on the evolution of cavitary lesions in nontuberculous mycobacterial pulmonary infection: thin-section CT and histopathologic correlation. AJR Am J Roentgenol, 2005,184(4):1247-1252.